Open Access

Long‑term effects of COVID‑19 in sickle cell disease: A case report

  • Authors:
    • Ricardo Wesley Alberca
    • Raquel Leão Orfali
    • Paula Ordonhez Rigato
    • Alberto José Da Silva Duarte
    • Valeria Aoki
    • Maria Notomi Sato
  • View Affiliations

  • Published online on: July 19, 2021     https://doi.org/10.3892/wasj.2021.117
  • Article Number: 46
  • Copyright: © Alberca et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection can generate a respiratory and systemic disease known as coronavirus disease 2019 (COVID‑19). To date, at least to the best of our knowledge, only a limited number of studies have identified SARS‑CoV‑2 infection in patients with sickle cell disease (SCD). Due to the lack of knowledge of the long‑term effects of COVID‑19, the present study presents the hematological alterations in a patient with SCD during hospitalization due to COVID‑19 and for up to 180 days following SARS‑CoV‑2 clearance and hospital discharge. The present study describes the case of a patient with SCD who was diagnosed with moderate COVID‑19 infection, without the need for invasive mechanical ventilation. Following SARS‑CoV‑2 clearance, long‑term (6 months) follow‑up identified an increase in the reticulocyte frequency, creatinine and D‑dimer levels. On the whole, the present study manuscript presents the case of a patient with moderate COVID‑19 infection with long‑term laboratory alterations at even 6 months following SARS‑CoV‑2 clearance. Further investigations are required however, to focus on the long‑term evaluations in patients who have recovered from COVID‑19, in order to fully determine the extension of possible sequelae.
View Figures
View References

Related Articles

Journal Cover

September-October 2021
Volume 3 Issue 5

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Alberca RW, Orfali RL, Rigato PO, Duarte AJ, Aoki V and Sato MN: Long‑term effects of COVID‑19 in sickle cell disease: A case report. World Acad Sci J 3: 46, 2021
APA
Alberca, R.W., Orfali, R.L., Rigato, P.O., Duarte, A.J., Aoki, V., & Sato, M.N. (2021). Long‑term effects of COVID‑19 in sickle cell disease: A case report. World Academy of Sciences Journal, 3, 46. https://doi.org/10.3892/wasj.2021.117
MLA
Alberca, R. W., Orfali, R. L., Rigato, P. O., Duarte, A. J., Aoki, V., Sato, M. N."Long‑term effects of COVID‑19 in sickle cell disease: A case report". World Academy of Sciences Journal 3.5 (2021): 46.
Chicago
Alberca, R. W., Orfali, R. L., Rigato, P. O., Duarte, A. J., Aoki, V., Sato, M. N."Long‑term effects of COVID‑19 in sickle cell disease: A case report". World Academy of Sciences Journal 3, no. 5 (2021): 46. https://doi.org/10.3892/wasj.2021.117